1.Tae Hyun Kim, Overcoming Endocrine Therapy Resistance in Breast Caner. Korean Journal of Clinical Oncology Winter 2009;.6(1): 22~28

2.Park WC, Kim LS, Kim TH, Park BW, Park HY, Song BJ, Lee JB, Jeon CW, Choi UJ. Molecular Targets for Treatment of Breast Cancer. J Breast Cancer. 2009;12(4): 229~234

3.Ping Fan, Wei Yue, Tae-Hyun Kim et al. Mechanisms of Resistance to Structurally Diverse Antiestrogens Differ under Premenopausal and Postmenopausal Conditions: Evidence from in Vitro Breast Cancer Cell Models. Endocrinology, May 2009, 151(5):2036

4.Yan Li, Richard J. Santen, Tae-Hyun Kim et al. Estrogen Stimulation of Cell Migration Involves Multiple Signaling Pathway Interactions. Endocrinology, November 2010, 151(11):5146

5.Taehyun Kim, Hoyong Park, Wei Yue, Ji-Ping Wang, Kristen A. Atkins, Zhenguo Zhang, Eleanor G. Rogan, Ercole L. Cavalieri, Khalid S. Mohammad, Sanghee Kim, Richard J. Santen, Sarah E. Aiyar. Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland. Breast Cancer Res Treat 2011; 126: 779-789

6.Seho Park, Byeong-Woo Park, Tae Hyun Kim, Chang Wan Jeon, Han-Sung Kang, Jung-Eun Choi, Ki-Tae Hwang, In Cheol Kim. Lack of Either Estrogen or Progesterone Receptor Expression Is Associated with Poor Survival Outcome among Luminal A Breast Cancer Subtype. Ann Surg Oncol. 2013 ;20(5):1505-13

7.Taehyun Kim, Heunglae Cho. The suitability of absorbable mesh insertion for oncoplastic breast surgery in patients with breast cancer scheduled to be irradiated. J Breast Cancer 2013, Mar 16:84

8.Hyunkeun Song, Tae Oh Kim, Sun Young Ma, Jin-Hee Park, Jae-Hyug Choi, Jin-Ho Kim, Mi Seon Kang, Sang Kyun Bae, Ki Hyaung Kim, Tae Hyun Kim, Su-Kil Seo, Il Whan Choi, Geun Am Song, Eric D Mortenson, Yang-Xin Fu, SaeGwang Park. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy. BMC Cancer 2014, 14:647

9.Seok Mo Lee, Sang Kyun Bae, Tae Hyun Kim, Hye Kyoung Yoon, Soo Jin Jung, Ji Sun Park, Chun K. Kim. Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy. Clinical Nuclear Medicine & Vol 39, Number 10, October 2014

10.Ahn HJ, Jung SJ, Kim TH, Oh MK, Yoon HK. Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen consensus 2013. J Breast Cancer 2015 June; 18(2): 149-159

11.Yoon MK, Jung SJ, Tae Hyun Kim, HanTK, Urm SH, Park JS, Lee SM, Bae SK. Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas. Endocr Res, 2015 Oct 29: 1?6

12.Sumin Ha, Tae Hyun Kim, Anbok Lee, Kyung-Do Byun, Jae Woong Han, Min Sung Ahn, Kwang Hee Kim, Ki Beom Bae,Ha Kyoung Park, Jae Ho Shin, Sang Hyuk Seo. Cosmetic outcomes and patients’ satisfaction of oncoplastic surgery in Korean patient with breast cancer. Korean J of Clinical Oncology 2015;11:67-73

13.Byun KD, Ahn SG, Lee AB, Jeong J, Tae Hyun Kim. Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports. J Breast Cancer 2016 June; 19(2): 214-217

14.Hyun-Ah Kim, Sei Hyun Ahn, Seok Jin Nam, Seho Park, Jungsil Ro, Seock-Ah Im, , Tae Hyun Kim, Se-Hwan Han, Woo Chul Noh. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress. BMC Cancer 2016; 16:319

15.Yunseon Choi, Sung Kwang Park, Ki Jung Ahn, Heunglae Cho, Tae Hyun Kim, Hye Kyoung Yoon, Yun-Han Lee. Being Overweight or Obese Increases the Risk of Progression in Triple-Negative Breast Cancer after Surgical Resection. J Korean Med Sci 2016; 31: 886-891

16.An Na Kwan, Tae Hyun Kim, Yun Me Lee. The influence of postoperative discomfort, sense of loss, and family support on resilience in patients after breast cancer surgery. J of Korean Critical Care Nursing 2017; 10: 34-44

17.Ye Won Jeon, Tae Hyun Kim, Hyun Jo Youn, Sehwan Han, Yongsik Jung, Geumhee Gwak, Young Sam Park, Jeong Soo Kim, Young Jin Suh. A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer. J Breast Cancer 2017 December; 20(4): 340-346

18.Hyun-Bin Ju, Eun-Chan Kang, Dong-Wook Jeon, Tae-Hyun Kim, Jung-Joon Moon, Sung-Jin Kim, Ji-Min Choi, and Do-Un Jung. Associations Among Plasma Stress Markers and Symptoms of Anxiety and Depression in Patients with Breast Cancer Following Surgery. Psychiatry Investig 2018;15(2):133-140

18.Hyun-Bin Ju, Eun-Chan Kang, Dong-Wook Jeon, Tae-Hyun Kim, Jung-Joon Moon, Sung-Jin Kim, Ji-Min Choi, and Do-Un Jung. Associations Among Plasma Stress Markers and Symptoms of Anxiety and Depression in Patients with Breast Cancer Following Surgery. Psychiatry Investig 2018;15(2):133-140

19.Hye Kyoung Yoona, Tae Hyun Kim,, SaeGwang Park, Hana Jung, Xingguo Quan, Seung Jae Park, Jaewoong Han, Anbok Lee. Effect of anthracycline and taxane on the expression of programmed cell death ligand-1 and galectin-9 in triple-negative breast cancer. Pathology - Research and Practice. 2018

20.In-Sung Song, Yu Jeong Jeong, Seung Hun Jeong, Ji Eun Kim, Jin Han, Tae-Hyun Kim, Sung-Wuk Jang. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function. Cell Physiol Biochem 2019;52:468-485

21.Hee Yeon Kim, Tae Hyun Kim, Hye Kyoung Yoon, Anbok Lee. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer. J Breast Cancer. 2019 Sep;22(3):425-438

22.Anbok Lee · Sunmi Jo · Changhu Lee · Hyun?Hee Shin · Tae Hyun Kim · Ki Jung Ahn · Sung?Kwang Park. Heunglae Cho · Hye?Kyoung Yoon · Woo Gyeong Kim · Jiyoung Park · Yunseon Choi. Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy. Breast Cancer (2019) 26:672?680

23.Jiwon Park, Yumi Shin, Tae Hyun Kim, Dong-Hyun Kim, Anbok Lee. Plasma metabolites as possible biomarkers for diagnosis of breast cancer. PLoS ONE 2019: 14(12): e0225129.

24.Hyun-Ah Kim, Jong Won Lee, Seok Jin Nam, Byeong-Woo Park, Seock-Ah Im, Eun Sook Lee, Yong Sik Jung, Jung Han Yoon, Sung Soo Kang, Soo-Jung Lee, Kyong Hwa Park, Joon Jeong, Se-Heon Cho, Sung Yong Kim, Lee Su Kim, Byung-In Moon Min Hyuk Lee, Tae Hyun Kim, Chanheun Park, Sung Hoo Jung, Geumhee Gwak, Jeryong Kim, Sun Hee Kang, Young Woo Jin, Hee Jeong Kim Se-Hwan Han, Wonshik Han, Min Hee Hur, and Woo Chul Noh on behalf of the Korean Breast Cancer Study Group. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial. J Clin Oncol 2019. 38:434-443.

25.Anbok Lee, Byung-In Moon, and Tae Hyun Kim. BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies. Ann Lab Med 2020;40:114-121